Thromb Haemost 1995; 74(02): 631-634
DOI: 10.1055/s-0038-1649789
Original Article
Clinical Studies
Schattauer GmbH Stuttgart

Demonstration of Rickettsia Conorii-Induced Coagulative and Platelet Activation in vivo in Patients with Mediterranean Spotted Fever

Giovanni Davì
The Department of Internal Medicine, University of Chieti, Italy
,
Carlo Giammarresi
1   The Department of Internal Medicine, University of Chieti, Palermo Italy
,
Sergio Vigneri
1   The Department of Internal Medicine, University of Chieti, Palermo Italy
,
Antonina Ganci
1   The Department of Internal Medicine, University of Chieti, Palermo Italy
,
Claudio Ferri
2   The Department of Internal Medicine, University of Chieti, Rome, Italy
,
Letizia Di Francesco
2   The Department of Internal Medicine, University of Chieti, Rome, Italy
,
Giustina Vitale
1   The Department of Internal Medicine, University of Chieti, Palermo Italy
,
Serafino Mansueto
1   The Department of Internal Medicine, University of Chieti, Palermo Italy
› Author Affiliations
Further Information

Publication History

Received 12 January 1995

Accepted after revision 08 March 1995

Publication Date:
06 July 2018 (online)

Summary

Endothelial injury in vivo induced by Rickettsia Conorii, the etiologic agent of Mediterranean Spotted Fever (MSF) has been recently demonstrated. We sought to determine whether platelet and/or coagulative activation in vivo can be demonstrated in the acute phase of MSF, through measurements of a major metabolite of thromboxane (TX) in the urine (1 1-dehydro-TXB2) and of plasma prothrombin fragment 1+2, whose levels reflect activation of prothrombin to thrombin. Moreover, we measured plasma endothelin-1 as marker of endothelial dysfunction. Our results provide biochemical evidence for the occurrence of TXA2-dependent platelet activation and thrombin generation in vivo, together with endothelial dysfunction. These phenomena could account for clinical manifestations of MSF, such as vasculitis and focal microthrombus formation. These results could also provide a rationale for testing the efficacy of aspirin or heparin in reducing the prothrombotic status of Rickettsiae diseases.

 
  • References

  • 1 Teysserie N, Arnoux D, George F, Sampol J, Raoult D. Von Willebrand factor release and thrombomodulin and tissue factor expression in Rickettsia Conorii-infected endothelial cells. Infect Immun 1992; 60: 4388-4393
  • 2 Walker DH. Pathology of Q fever. In: Biology of Rickettsial Diseases, Vol II. Walker DH. ed. Boca Raton FL: CRC press; 1988: 17-27
  • 3 Rao AK, Schapira M, Clements ML, Niewiarowski S, Budzynski AZ, Schmaier AH, Horpel PC, Blackwelder WC, Scherrer JR, Sobel E. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. N Engl J Med 1988; 318: 1021-1028
  • 4 Vicente V, Alberca I, Ruiz R, Herrero I, Gonzalez R, Portugal J. Coagulation abnormalities in patients with Mediterranean spotted fever. J Infect Dis 1986; 153: 128-131
  • 5 Vicente V, Espana F, Tabemero D, Estelles A, Aznar J, Hendl S, Griffin JH. Evidence of activation of the protein C pathway during acute vascular damage induced by Meditteranean spotted fever. Blood 1991; 78: 416-422
  • 6 Drancourt M, Alessi MC, Levy PY, Juhan-Vague I, Raoult D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia Conorii- and Rickettsia Rickettsii-infected cultured endothelial cells. Infect Immun 1990; 58: 2459-2463
  • 7 Silverman DJ. Adherence of platelets to human endothelial cells infected by Rickettsia Rickettsii. J Infect Dis 1986; 153: 694-700
  • 8 George F, Brouqui P, Boffa MC, Mutin M, Drancourt M, Brisson C, Raoult D, Sampol J. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with mediterranean spotted fever. Blood 1993; 82: 2109-2116
  • 9 Patrono C, Davì G, Ciabattoni G. Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors. Trends Cardiovasc Med 1992; 2: 15-20
  • 10 Bauer KA, Rosenberg RD. The pathophysiology of the prothrombotic state in humans: Insights gained from studies using markers of hemostatic system activation. Blood 1987; 70: 343-350
  • 11 Mansueto S, Tringali G, Walker DH. Widespread, simultaneous increase in the incidence of spotted fever group Rickettsiosis. J Inf Dis 1986; 154: 539-540
  • 12 Mansueto S, Vitale G, Mocciaro C. Laboratory diagnosis of boutonneuse fever by enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg 1989; 83: 855-857
  • 13 Wagner OF, Nowotny P, Vierhapper H, Waldhausl W. Plasma concentrations of endothelin in man: Arterio-venous differences and release during venous stasis. Eur J Clin Invest 1990; 20: 502-5
  • 14 Ciabattoni G, MacLouf J, Catella F, FitzGerald GA, Patrono C. Radioimmunoassay of 11-dehydro-thromboxane B2in human plasma and urine. Biochim Biophys Acta 1987; 918: 293-297
  • 15 Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153-159
  • 16 Siegel S. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill; 1956: 184
  • 17 Sbarbati R, De Boer M, Marzilli M, Scarlattini M, Rossi G, Van Mourik J. Immunologic detection of endothelial cells in human whole blood. Blood 1991; 77: 764-769
  • 18 Drancourt M, George F, Brouqui P, Sampol J, Raoult D. Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads. J Infect Dis 1992; 166: 660-3
  • 19 Walker DH, Harrison A, Henderson F, Murphy FA. Identification of Rickettsia Rickettsii in a guinea pig model by immunofluorescent and electron microscopic techniques. Am J Pathol 1977; 86: 343-348
  • 20 Sporn LA, Haidaris PJ, Shi RJ, Nemerson Y, Silverman DJ, Marder VJ. Rickettsia rickettsii infection of cultured human endothelial cells induces tissue factor expression. Blood 1994; 83: 1527-1534
  • 21 Davì G, Catalano I, Avema M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990; 322: 1769-1774
  • 22 Davì G, Averna M, Catalano I, Barbagallo C, Ganci A, Notarbartolo A, Ciabattoni G, Patrono C. Increased thromboxane biosynthesis in type Ha hypercholesterolemia. Circulation 1992; 85: 1792-1798
  • 23 Di Minno G, Davì G, Margaglione M, Cirillo F, Grandone E, Ciabattoni G, Catalano I, Strisciuglio P, Andria G, Patrono C, Mancini M. Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism J Clin Invest 1993; 92: 1400-1406
  • 24 Walker DH, Mattern WD. Rickettsial vasculitis. Am Heart J 1980; 100: 896-906